We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Inverse US Treasury ETN (TAPR) Hits New 52-Week Low
For investors interested in finding out the painful areas of investing, Barclays Inverse US Treasury Composite ETN is probably on radar now. The product just hit a 52-week low, and shares of TAPR are down roughly 60.2% from their 52-week high price of $40.84/share.
Are more pains in store for this ETN? Let’s take a quick look at the fund and its near-term outlook to get a better idea of where it might be headed:
TAPR in Focus
The note follows the Barclays Inverse US Treasury Futures Composite Index. This benchmark looks to track the sum of the returns of the periodically rebalanced short positions in equal face values of each of the 2-year, 5-year, 10-year, long-bond and ultra-long U.S. Treasury futures contracts (see all inverse bond ETFs here).
Why the Move?
The Brexit dampened risk-on sentiments across the globe badly and inspired risk-off trade. All safe assets like the U.S. Treasury bonds benefited from Brexit. With global growth falling prey to this event, investors’ rate hike worries even in the U.S. seem non-existent at the current level. This explains the latest move in the inverse U.S. Treasury ETN.
More Pains Ahead?
The note has a negative weighted alpha of 61.13. A negative weighted alpha hints at more pains.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>